Product NDC: | 0006-3822 |
Proprietary Name: | CANCIDAS |
Non Proprietary Name: | CASPOFUNGIN ACETATE |
Active Ingredient(s): | 5 mg/mL & nbsp; CASPOFUNGIN ACETATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0006-3822 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021227 |
Marketing Category: | NDA |
Start Marketing Date: | 20010126 |
Package NDC: | 0006-3822-10 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0006-3822-10) > 10.8 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0006-3822-10 |
Proprietary Name | CANCIDAS |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0006-3822-10) > 10.8 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0006-3822 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CASPOFUNGIN ACETATE |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010126 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | CASPOFUNGIN ACETATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] |